LLY Valuation

Eli Lilly and Co

Add to Watchlist

Advanced Chart

737.830

+2.64(0.359%)1D

Overview
Forecast
Valuation
Earnings

LLY Relative Valuation

LLY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LLY is overvalued; if below, it's undervalued.

Historical Valuation

Eli Lilly and Co (LLY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 26.52 is considered Undervalued compared with the five-year average of 39.62. The fair price of Eli Lilly and Co (LLY) is between 810.23 to 1368.76 according to relative valuation methord. Compared to the current price of 736.83 USD , Eli Lilly and Co is Undervalued By 9.06%.

Relative Value

Fair Zone

810.23-1368.76

Current Price：736.83

9.06%

Undervalued

26.61

Trailing

Forward

21.54

EV/EBITDA

Eli Lilly and Co. (LLY) has a current EV/EBITDA of 21.54. The 5-year average EV/EBITDA is 29.65. The thresholds are as follows: Strongly Undervalued below 13.18, Undervalued between 13.18 and 21.41, Fairly Valued between 37.89 and 21.41, Overvalued between 37.89 and 46.12, and Strongly Overvalued above 46.12. The current Forward EV/EBITDA of 21.54 falls within the Historic Trend Line -Fairly Valued range.

23.29

EV/EBIT

Eli Lilly and Co. (LLY) has a current EV/EBIT of 23.29. The 5-year average EV/EBIT is 34.57. The thresholds are as follows: Strongly Undervalued below 14.02, Undervalued between 14.02 and 24.30, Fairly Valued between 44.85 and 24.30, Overvalued between 44.85 and 55.13, and Strongly Overvalued above 55.13. The current Forward EV/EBIT of 23.29 falls within the Undervalued range.

9.81

Eli Lilly and Co. (LLY) has a current PS of 9.81. The 5-year average PS is 10.68. The thresholds are as follows: Strongly Undervalued below 4.33, Undervalued between 4.33 and 7.50, Fairly Valued between 13.86 and 7.50, Overvalued between 13.86 and 17.03, and Strongly Overvalued above 17.03. The current Forward PS of 9.81 falls within the Historic Trend Line -Fairly Valued range.

29.65

P/OCF

Eli Lilly and Co. (LLY) has a current P/OCF of 29.65. The 5-year average P/OCF is 37.66. The thresholds are as follows: Strongly Undervalued below 12.77, Undervalued between 12.77 and 25.21, Fairly Valued between 50.11 and 25.21, Overvalued between 50.11 and 62.55, and Strongly Overvalued above 62.55. The current Forward P/OCF of 29.65 falls within the Historic Trend Line -Fairly Valued range.

46.11

P/FCF

Eli Lilly and Co. (LLY) has a current P/FCF of 46.11. The 5-year average P/FCF is 49.12. The thresholds are as follows: Strongly Undervalued below 11.53, Undervalued between 11.53 and 30.32, Fairly Valued between 67.91 and 30.32, Overvalued between 67.91 and 86.70, and Strongly Overvalued above 86.70. The current Forward P/FCF of 46.11 falls within the Historic Trend Line -Fairly Valued range.

Eli Lilly and Co (LLY) has a current Price-to-Book (P/B) ratio of 36.08. Compared to its 3-year average P/B ratio of 45.59 , the current P/B ratio is approximately -20.85% higher. Relative to its 5-year average P/B ratio of 39.21, the current P/B ratio is about -7.97% higher. Eli Lilly and Co (LLY) has a Forward Free Cash Flow (FCF) yield of approximately 0.74%. Compared to its 3-year average FCF yield of 0.71%, the current FCF yield is approximately 3.74% lower. Relative to its 5-year average FCF yield of 1.59% , the current FCF yield is about -53.38% lower.

36.21

P/B

Median3y

45.59

Median5y

39.21

0.74

FCF Yield

Median3y

0.71

Median5y

1.59

Competitors Valuation Multiple

The average P/S ratio for LLY's competitors is 5.67, providing a benchmark for relative valuation. Eli Lilly and Co Corp (LLY) exhibits a P/S ratio of 9.81, which is 72.87% above the industry average. Given its robust revenue growth of 37.64%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Dr Reddy's Laboratories Ltd

Performance Decomposition

Market capitalization of LLY decreased by 17.02% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 26.25 to 36.38.

The secondary factor is the Revenue Growth, contributed 37.64%to the performance.

Overall, the performance of LLY in the past 1 year is driven by Margin Expansion. Which is more sustainable.

37.64%

11.30B → 15.56B

Revenue Growth

38.59%

26.25 → 36.38

Margin Expansion

-93.25%

714.78 → 48.25

P/E Change

-17.02%